sulfur hexafluoride has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cosgrove, D; Lassau, N; Leguerney, I; Peronneau, P; Roche, A | 1 |
| Bawa, O; Benatsou, B; Koscielny, S; Lassau, N; Leguerney, I; Massard, C; Opolon, P; Peronneau, P; Roche, A; Rodrigues, M; Rouffiac, V; Thalmensi, J | 1 |
2 other study(ies) available for sulfur hexafluoride and B16 Melanoma
| Article | Year |
|---|---|
Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization.
Topics: Angiogenesis Inhibitors; Animals; Blood Flow Velocity; Contrast Media; Female; Image Enhancement; Image Processing, Computer-Assisted; Linear Models; Melanoma, Experimental; Mice; Mice, Nude; Microcirculation; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Phantoms, Imaging; Phospholipids; Regional Blood Flow; Serine; Sulfur Hexafluoride; Ultrasonography, Doppler; Videotape Recording | 2010 |
Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Contrast Media; Drug Administration Schedule; Extracellular Fluid; Female; Fiber Optic Technology; Melanoma, Experimental; Mice; Neovascularization, Pathologic; Niacinamide; Perfusion Imaging; Phenylurea Compounds; Phospholipids; Pressure; Pyridines; Regional Blood Flow; Sorafenib; Sulfur Hexafluoride; Time Factors; Transducers, Pressure; Ultrasonography, Doppler | 2012 |